close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

QuidelOrtho Corporation - Common Stock (NQ:QDEL)

29.48 +0.38 (+1.29%)
Streaming Delayed Price Updated: 3:25 PM EST, Feb 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about QuidelOrtho Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
QuidelOrtho Announces Changes in Executive Leadership
From QuidelOrtho Corporation
Via Business Wire
News headline image
Berman Tabacco Announces Investigation of QuidelOrtho Corporation (QDEL) for Potential Securities Law Violations
From Berman Tabacco
Via GlobeNewswire
News headline image
QuidelOrtho Reports Fourth Quarter and Full-Year 2023 Financial Results
From QuidelOrtho Corporation
Via Business Wire
News headline image
QuidelOrtho to Report Fourth Quarter and Full-year 2023 Financial Results
From QuidelOrtho Corporation
Via Business Wire
News headline image
QuidelOrtho to Present at 42nd Annual J.P. Morgan Healthcare Conference
From QuidelOrtho Corporation
Via Business Wire
News headline image
QuidelOrtho Receives 510(K) Clearance for Savanna® Multiplex Molecular Platform and Savanna® HSV 1+2/VZV PCR Assay
From QuidelOrtho Corporation
Via Business Wire
News headline image
QuidelOrtho to Participate in the Evercore ISI Conference
From QuidelOrtho Corporation
Via Business Wire
News headline image
QuidelOrtho Reports Third Quarter 2023 Financial Results
From QuidelOrtho Corporation
Via Business Wire
News headline image
QuidelOrtho Reports Preliminary Revenue Results for the Third Quarter 2023
From QuidelOrtho Corporation
Via Business Wire
News headline image
QuidelOrtho Receives CLIA Waiver for Sofia® 2 SARS Antigen+ FIA
From QuidelOrtho Corporation
Via Business Wire
News headline image
QuidelOrtho to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
From QuidelOrtho Corporation
Via Business Wire
News headline image
QuidelOrtho Reports Second Quarter 2023 Financial Results
From QuidelOrtho Corporation
Via Business Wire
News headline image
QuidelOrtho Ranks No. 1 in Customer Satisfaction for Six Years in a Row
From QuidelOrtho Corporation
Via Business Wire
News headline image
QuidelOrtho Partners With BYG4lab® to Strengthen Informatics Offerings
From QuidelOrtho Corporation
Via Business Wire
News headline image
QuidelOrtho to Report Second Quarter 2023 Financial Results
From QuidelOrtho Corporation
Via Business Wire
News headline image
QuidelOrtho to Participate in William Blair 43rd Annual Growth Stock Conference
From QuidelOrtho Corporation
Via Business Wire
News headline image
QuidelOrtho Reports First Quarter 2023 Financial Results
From QuidelOrtho Corporation
Via Business Wire
News headline image
QuidelOrtho Reports Preliminary Revenue Results for the First Quarter 2023
From QuidelOrtho Corporation
Via Business Wire
News headline image
QuidelOrtho Announces the Formation of the International QuidelOrtho Women’s Leadership Network (QWLN)
From QuidelOrtho Corporation
Via Business Wire
News headline image
QuidelOrtho Receives De Novo FDA Authorization for Sofia® 2 SARS Antigen+ FIA
From QuidelOrtho Corporation
Via Business Wire
News headline image
QuidelOrtho to Participate in the Raymond James 44th Annual Institutional Investor Conference
From QuidelOrtho Corporation
Via Business Wire
News headline image
Lucira Stock Jumps over 250% on FDA Approval, Beware Chapter 11
Lucira Health Inc. (NASDAQ: LHDX) shares spiked up 264% to close at $0.52 on a massive 278 million shares traded on the announcement of FDA approval for its 
Via MarketBeat
Topics Initial Public Offering
News headline image
QuidelOrtho Reports Fourth Quarter and Full Year 2022 Financial Results
From QuidelOrtho Corporation
Via Business Wire
News headline image
QuidelOrtho Reports Preliminary Revenue Results for Fourth Quarter and Full Year 2022
From QuidelOrtho Corporation
Via Business Wire
News headline image
QuidelOrtho to Present at the J.P. Morgan Healthcare Conference
From QuidelOrtho Corporation
Via Business Wire
News headline image
QuidelOrtho and Runda Medical Form Joint Venture to Develop and Manufacture Assays for VITROS® Platform
From QuidelOrtho Corporation
Via Business Wire
News headline image
QuidelOrtho Announces Separation of Chairman and Chief Executive Officer Roles
From QuidelOrtho Corporation
Via Business Wire
News headline image
QuidelOrtho to Host Investor Day on December 13, 2022
From QuidelOrtho Corporation
Via Business Wire
News headline image
QuidelOrtho Reports Third Quarter 2022 Financial Results
From QuidelOrtho Corporation
Via Business Wire
News headline image
QuidelOrtho Reports Preliminary Revenue Results for Third Quarter 2022
From QuidelOrtho Corporation
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today